MRMD — Marimed Cashflow Statement
0.000.00%
- $64.54m
- $119.71m
- $148.60m
- 46
- 93
- 27
- 56
Annual cashflow statement for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -81.2 | 2.14 | 7.22 | 13.5 | -16 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 87.4 | 7.31 | 19.2 | 11.1 | 16.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -31.6 | -8.26 | 6.69 | -21.9 | -1.29 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -24.1 | 3.38 | 35.9 | 7.31 | 7.91 |
Capital Expenditures | -9.98 | -4.94 | -18.6 | -12.7 | -20.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2.56 | 0.48 | 1.94 | -13.5 | -5.23 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.5 | -4.46 | -16.6 | -26.2 | -26 |
Financing Cash Flow Items | -0.474 | -0.309 | -0.41 | -2.26 | -4.41 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 33.3 | 3.34 | 7.45 | -1.01 | 23 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.37 | 2.26 | 26.7 | -19.9 | 4.91 |